Nearly 2 decades ago, the discovery of TDP-43 aggregates in the brains of patients with ALS and FTD revolutionized the neurodegenerative disease field (47) and set the stage for intense research into the role of TDP-43 dysfunction in ALS/FTD and related disorders. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.